港股異動 | 中煙香港(6055.HK)漲超6% 去年純利同比大增562.3%
格隆匯3月15日丨中煙香港(6055.HK)股價直線拉昇,現報13.2港元,漲幅6.45%,總市值91.3億港元。公司昨日公吿稱,截至2021年12月31日止年度收入為80.64億港元,同比增長131.42%;公司權益持有人應占年內利潤為7.03億港元,同比增長562.29%。主要由於2020年度延遲裝運的煙葉類進口產品於截至2021年12月31日止年度陸續到港,令截至2021年12月31日止年度煙葉類產品進口業務收入及應占合營企業溢利較2020年度大幅上升。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.